Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 2588

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 8
Chunk 2588
---
 31, 2024, 566,908 shares of Common
Stock and 76,480 shares of Series A Preferred Stock are issued and outstanding.

Following stockholder approval in July 2024,
on July 30, 2024, the Company filed an Amendment to the Certificate of Incorporation with the Secretary of State of Delaware to effect
the 1:12 Reverse Stock Split of the issued and outstanding shares of the Company’s common stock, which was effective as of August
12, 2024. As of the effective time of the 1:12 Reverse Stock Split, every twelve (12) issued and outstanding shares of the Company’s
common stock were automatically combined and converted into one (1) issued and outstanding share of the Company’s common stock,
reducing the number of shares of common stock outstanding from 21,219,937 shares to 1,768,337 shares (not including the effects of the
1:5 Reverse Stock Split discussed below). No fractional shares of common stock were issued in connection with the Reverse Stock Split
and all fractional shares were rounded up to the nearest whole share with respect to outstanding shares of common stock. The Company
issued an additional 18,710 shares of common stock on August 19, 2024 for rounding due to fractional shares (93,563 not including the
effects of the 1:5 Reverse Stock Split discussed below).

Following stockholder approval in November 2024,
on February 18, 2025, the Company filed an additional Amendment to the Certificate of Incorporation with the Secretary of State of Delaware
to effect the 1:5 Reverse Stock Split of the issued and outstanding shares of the Company’s common stock, which was effective as
of February 24, 2025. As of the effective time of the 1:5 Reverse Stock Split, every five (5) issued and outstanding shares of the Company’s
common stock were automatically combined and converted into one (1) issued and outstanding share of the Company’s common stock,
reducing the number of shares of common stock outstanding from 7,364,554 shares to 1,472,891 shares. No fractional shares of common stock
were issued in connection with the 1:5 Reverse Stock Split. All fractional shares were rounded up to the nearest whole share with respect
to outstanding shares of common stock. See Note 12 - Subsequent Events.

The Reverse Stock Splits did not change the authorized
number of shares of common stock